163 related articles for article (PubMed ID: 10222050)
21. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
22. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
[TBL] [Abstract][Full Text] [Related]
23. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
[TBL] [Abstract][Full Text] [Related]
24. The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells.
Siissalo S; Zhang H; Stilgenbauer E; Kaukonen AM; Hirvonen J; Finel M
Drug Metab Dispos; 2008 Nov; 36(11):2331-6. PubMed ID: 18694909
[TBL] [Abstract][Full Text] [Related]
25. UDP-glucuronosyltransferases (UGTs) 2B7 and UGT2B17 display converse specificity in testosterone and epitestosterone glucuronidation, whereas UGT2A1 conjugates both androgens similarly.
Sten T; Bichlmaier I; Kuuranne T; Leinonen A; Yli-Kauhaluoma J; Finel M
Drug Metab Dispos; 2009 Feb; 37(2):417-23. PubMed ID: 19022937
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical localization of UDP-glucuronosyltransferases in rat brain during early development.
Martinasevic MK; King CD; Rios GR; Tephly TR
Drug Metab Dispos; 1998 Oct; 26(10):1039-41. PubMed ID: 9763411
[TBL] [Abstract][Full Text] [Related]
27. Interactions with other human UDP-glucuronosyltransferases attenuate the consequences of the Y485D mutation on the activity and substrate affinity of UGT1A6.
Kurkela M; Patana AS; Mackenzie PI; Court MH; Tate CG; Hirvonen J; Goldman A; Finel M
Pharmacogenet Genomics; 2007 Feb; 17(2):115-26. PubMed ID: 17301691
[TBL] [Abstract][Full Text] [Related]
28. Steviol glucuronidation and its potential interaction with UDP-glucuronosyltransferase 2B7 substrates.
Wang M; Lu J; Li J; Qi H; Wang Y; Zhang H
Food Chem Toxicol; 2014 Feb; 64():135-43. PubMed ID: 24296138
[TBL] [Abstract][Full Text] [Related]
29. Human renal cortical and medullary UDP-glucuronosyltransferases (UGTs): immunohistochemical localization of UGT2B7 and UGT1A enzymes and kinetic characterization of S-naproxen glucuronidation.
Gaganis P; Miners JO; Brennan JS; Thomas A; Knights KM
J Pharmacol Exp Ther; 2007 Nov; 323(2):422-30. PubMed ID: 17698974
[TBL] [Abstract][Full Text] [Related]
30. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
Sten T; Qvisen S; Uutela P; Luukkanen L; Kostiainen R; Finel M
Drug Metab Dispos; 2006 Sep; 34(9):1488-94. PubMed ID: 16763014
[TBL] [Abstract][Full Text] [Related]
31. Activity and expression of various isoforms of uridine diphosphate glucuronosyltransferase are differentially regulated during hepatic regeneration in rats.
Tian H; Ou J; Strom SC; Venkataramanan R
Pharm Res; 2005 Dec; 22(12):2007-15. PubMed ID: 16222444
[TBL] [Abstract][Full Text] [Related]
32. The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan.
Alonen A; Finel M; Kostiainen R
Biochem Pharmacol; 2008 Sep; 76(6):763-72. PubMed ID: 18674515
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
[TBL] [Abstract][Full Text] [Related]
34. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation.
Nishiyama T; Ohnuma T; Inoue Y; Kishi T; Ogura K; Hiratsuka A
Biochem Biophys Res Commun; 2008 Jun; 371(2):247-50. PubMed ID: 18423374
[TBL] [Abstract][Full Text] [Related]
35. Transcriptional regulation of human UDP-glucuronosyltransferase genes.
Hu DG; Meech R; McKinnon RA; Mackenzie PI
Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387
[TBL] [Abstract][Full Text] [Related]
36. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
[TBL] [Abstract][Full Text] [Related]
37. The effects of N-glycosylation on the glucuronidation of zidovudine and morphine by UGT2B7 expressed in HEK293 cells.
Nagaoka K; Hanioka N; Ikushiro S; Yamano S; Narimatsu S
Drug Metab Pharmacokinet; 2012; 27(4):388-97. PubMed ID: 22240840
[TBL] [Abstract][Full Text] [Related]
38. Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction.
Ohno S; Nakajin S
Drug Metab Dispos; 2009 Jan; 37(1):32-40. PubMed ID: 18838504
[TBL] [Abstract][Full Text] [Related]
39. Tissue-specific regulation of canine intestinal and hepatic phenol and morphine UDP-glucuronosyltransferases by beta-naphthoflavone in comparison with humans.
Bock KW; Bock-Hennig BS; Münzel PA; Brandenburg JO; Köhle CT; Soars MG; Riley RJ; Burchell B; von Richter O; Eichelbaum MF; Swedmark S; Orzechowski A
Biochem Pharmacol; 2002 May; 63(9):1683-90. PubMed ID: 12007571
[TBL] [Abstract][Full Text] [Related]
40. Expression and inducibility of UDP-glucuronosyltransferase 1As in MCF-7 human breast carcinoma cells.
Hanioka N; Iwabu H; Hanafusa H; Nakada S; Narimatsu S
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):253-8. PubMed ID: 21902811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
